#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Undifferentiated sarcoma Stiff person syndrome Porphyria non-acute Autoimmune haemolytic anaemia Marfan's syndrome Hypereosinophilic syndrome Gastroenteropancreatic neuroendocrine tumour disease NTRK gene fusion overexpression Breast angiosarcoma Chorioretinitis B precursor type acute leukaemia Oesophageal adenocarcinoma stage II Angiosarcoma metastatic Adenoid cystic carcinoma Factor IX deficiency More trials…

    Learn about Rare Diseases

    Antisynthetase syndrome – Treatment Von Willebrand’s disease – Diagnostics Factor VIII deficiency – Treatment Chondrosarcoma – Trials in Disease Soft tissue sarcoma Nephroblastoma – Treatment Wiskott-Aldrich syndrome – Life with Disease Basal cell naevus syndrome – Trials in Disease Pleomorphic leiomyosarcoma – Basic Information Toxic epidermal necrolysis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ucp2 Sultiame Quinine Dihydrochloride Dazucorilant POLYSORBATE 80 Pravastatin Sodium Human Albumin Solution Nacubactam Vonafexor Clofarabine Amg 193 RO7284755 Potassium Canrenoate Sodium 2-Hydroxylinoleate Inotuzumab Ozogamicin Cx-037231 DROSPIRENONE Concizumab Myrrh Emedastine More therapies…

    Learn about Your Condition

    Peritoneal dialysis Gaucher's disease type III Leber's congenital amaurosis Organ donor Blood disorder Andersen-Tawil syndrome Still's disease Metabolic surgery Inborn error of metabolism Diabetes mellitus Chondrosarcoma metastatic Vulval cancer recurrent Coronary artery bypass Metabolic disorder Urticaria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ovarian cancer stage III

  • Study on Letrozole vs. Chemotherapy (Carboplatin and Paclitaxel) for Patients with Advanced Low-Grade Serous Ovarian Cancer with Hormone Receptors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer stage IV
    • Ovarian cancer stage III
    Investigated Drugs:
    • Letrozole
    • Carboplatin
    • Paclitaxel
    Czechia Italy

  • Study on Niraparib, Carboplatin, and Paclitaxel for Advanced Ovarian Cancer Patients After Tumor Removal

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer stage III
    • Fallopian tube cancer stage IV
    • Ovarian cancer stage IV
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Carboplatin
    • Paclitaxel
    Austria Belgium Czechia Germany Italy Spain

  • Study on the Effects of Tinzaparin on Biomarkers in Advanced Ovarian Cancer Patients Receiving Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer stage IV
    • Ovarian cancer stage III
    • Ovarian cancer
    Investigated Drugs:
    • Tinzaparin Sodium
    Sweden

  • Study on Adjusting Chemotherapy with Carboplatin and Paclitaxel for Patients with Poor Prognostic Ovarian Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Filgrastim
    • Bevacizumab
    • Carboplatin
    France Italy The Netherlands

  • Study of Niraparib and Dostarlimab Combined with Platinum Therapy for Newly Diagnosed Stage III or IV Non-mucinous Epithelial Ovarian Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Dostarlimab
    • Niraparib Tosilate Monohydrate
    Belgium Czechia Denmark Finland France Germany +7

  • Study on the Effect of Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Stage III Ovarian Cancer Patients Undergoing Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer stage III
    Investigated Drugs:
    • Sodium Thiosulfate
    • Bevacizumab
    • Carboplatin
    Denmark France Germany Ireland Italy The Netherlands +1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!